Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101

NCT06545162 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.